Prosecution Insights
Last updated: April 19, 2026

Changchun Genescience Pharmaceutical Co. Ltd.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18245293 APPLICATION OF ESTER GROUP-CONTAINING AROMATIC PROPIONAMIDE COMPOUNDS IN PREPARATION OF DRUGS FOR TREATING URINARY INCONTINENCE WELLS, LAUREN QUINLAN 1622 Non-Final OA Mar 14, 2023
18245055 USE OF ESTER GROUP-CONTAINING AROMATIC PROPIONAMIDE COMPOUND IN PREPARATION OF MEDICINE FOR TREATING DRY EYE SYNDROME SOROUSH, ALI 1614 Final Rejection Mar 13, 2023

Managing Changchun Genescience Pharmaceutical Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month